Maryland’s biohealth boom continues, with Australian bio company Ellume announcing its entrance in the United States. Ellume, a Queensland digital diagnostics company, recently signed a $231.8 million agreement with the federal government to accelerate domestic production of its COVID-19 home tests. The company will establish a manufacturing facility in Maryland, its first in the United States, to accommodate the demand for its products targeting infectious diseases.
{iframe}https://open.maryland.gov/blog/australian-bio-business-brings-1500-jobs-maryland-new-manufacturing-facility/?utm_source=Maryland+Department+of+Commerce+%28MAIN+LIST%29&utm_campaign=9d573e1155-EMAIL_CAMPAIGN_2020_01_24_06_05_COPY_01&utm_medium=email&utm_term=0_f78deb20ad-9d573e1155-142072933{/iframe}